Results 161 to 170 of about 50,246 (189)

An unusual presenting feature of precursor T-cell acute lymphoblastic leukemia/lymphoma

Annals of Hematology, 2005
Precursor T-acute lymphoblastic leukemia/lymphoma (ALL) comprises approximately 20–25% of adult cases of ALL. Precursor T-ALL tends to present in adolescent males as lymphomas and is characteristically presented with a high leukocyte count or large mediastinal mass at initial presentation.
Me-Ae Kim, Gyeong-Won Lee, Kook-Young Maeng   +2 more
openaire   +1 more source

Human medicines European public assessment report (EPAR): Oncaspar, pegaspargase, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 14/01/2016, Revision: 8, Status: Authorised

Case Medical Research, 2019
openaire   +2 more sources

Precursor T-cell acute lymphoblastic leukemia/lymphoma involving the uterine cervix, myometrium, endometrium, and appendix

Annals of Diagnostic Pathology, 2002
This report presents a case of precursor T-cell acute lymphoblastic leukemia/lymphoma (ALL) involving the uterine cervix, myometrium, endometrium, and appendix. The patient was a 38-year-old woman with a history of ALL who had been in remission for 4 years following chemotherapy.
Mark D, Lyman, Thomas S, Neuhauser
openaire   +2 more sources

Abstract 3098: Myc preferentially transforms hematopoietic stem cells into Precursor B cell lymphoblastic leukemia/lymphoma

Cancer Research, 2010
Abstract Overexpression of Myc oncogenes (c-Myc, N-Myc and L-Myc) is frequently found in a wide range of tumors. Although many reports have shown that Myc can directly induce tumors in mice models, the cell-of-origin of the Myc-induced tumor is still unclear.
Eiji Sugihara, Takatsune Shimizu, Jo Ishizawa, Seiji Okada, Masanao Miwa, Hideyuki Saya   +5 more
openaire   +1 more source

Human medicines European public assessment report (EPAR): Besponsa, inotuzumab ozogamicin, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Date of authorisation: 28/06/2017, Revision: 3, Status: Authorised

Case Medical Research, 2018
openaire   +2 more sources

Clinicopathological differences between T-lymphoblastic leukemia/lymphoma, early T-precursor lymphoblastic leukemia/lymphoma, and mixed-phenotype acute leukemia with T lineage: An analysis of 41 adult cases

Human Pathology
The histopathological diagnosis of T-lymphoblastic leukemia/lymphoma, NOS (T-ALL), is based on morphology and positivity for CD3 and TdT. Early T-precursor lymphoblastic leukemia/lymphoma (ETP-ALL) and mixed-phenotype acute leukemia (MPAL), T/M, and/or B
Akiko Maeshima, Tetsuro Ochi, Noriko Iwaki   +2 more
exaly   +2 more sources

Additional flow cytometric studies for differential diagnosis between Burkitt lymphoma/leukemia and B-cell precursor acute lymphoblastic leukemia.

Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis, 2020
The differentiation between Burkitt lymphoma/leukemia (BL) and B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is sometimes complicated. Laboratory findings that favor BL (e.g., surface expression of μ heavy chain and/or one of the light chains ...
I. Demina, Alexander Voropayev, A. Semchenkova, E. Zerkalenkova, Y. Olshanskaya, E. Samochatova, G. Novichkova, N. Miakova, A. Maschan, A. Popov   +9 more
semanticscholar   +1 more source

Li-Fraumeni syndrome presenting as precursor B lymphoblastic leukemia mimicking intravascular large B-cell lymphoma

Blood, 2019
Annette Kim, Kim Annette S
exaly   +2 more sources

Academic, Phase I/II Trial on T Cells Expressing a Second Generation, CD19-Specific Chimeric Antigen Receptor (CAR) and Inducible Caspase 9 Safety Switch for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) and B-Cell Non-Hodgkin Lymphoma (B-NHL) in Children

Blood, 2019
Survival rates of children with relapsed/refractory (r/r) BCP-ALL remain unsatisfactory and little progress has been made in the past 2 decades. Similarly, relapse of childhood B-NHL is usually associated with an aggressive disease and poor outcomes ...
F. Bufalo, C. Quintarelli, B. D. Angelis, Ignazio Caruana, M. Sinibaldi, L. Vinti, P. Merli, M. Algeri, A. Ruggeri, F. Galaverna, Valentina Cirillo, M. Cefalo, G. Pira, Giovanna Leone, V. Bertaina, F. Fassio, M. Gunetti, S. Iacovelli, F. Locatelli   +18 more
semanticscholar   +1 more source

T and NK lymphoblastic leukemia/lymphoma: Report from the 2023 SH/EAHP Workshop.

American Journal of Clinical Pathology
OBJECTIVES The 2023 Society for Hematopathology/European Association for Hematopathology Workshop addressed advancements in the diagnosis and classification of T- and natural killer (NK)-cell lymphomas/leukemias.
O. Weinberg, C. Bueso-Ramos, R. Kanagal-Shamanna   +2 more
semanticscholar   +1 more source